5.23.25
7 min. Read

PHTI’s premature PDT pricing analysis. CPT billing code rejects.

Issue 247

Welcome back to E&O: SaMD, a paying subscribers-only weekly newsletter focused on the world of digital pharma products, prescription digital therapeutics and other FDA-regulated digital health.

 E&O: Software as a Medical Device

 

Here's two quick notes before we get into new CPT billing code application rejections and the latest PHTI assessment, which used some curious numbers to conclude that mental health-focused PDTs should be

Paying Subscribers Only

It's a good one, too.
This digital health research is for paying Exits & Outcomes subscribers only. Subscribe now to read this article, get the weekly newsletter, and receive unrestricted access to past and future research from the Exits & Outcomes archives. Smash the link above or below to subscribe yourself -- or head over to our pricing page to subscribe your team or your whole company!
×

Full access to E&O's research and newsletters.

Get the subscribers-only newsletters + research reports + databases
CMS to pay for ADHD DTx. More PFS notes. Two FDA De Novos.
11.07.25
6 min. Read
Pricing for Sword Health, Hinge Health, Joint Academy in the UK.
10.31.25
7 min. Read
Spring, Slingshot AI, Click and others write FDA about GenAI. Big Health board departs.
10.24.25
7 min. Read
Cigna clarifies new non-coverage policy for PDTs. Bevel $10M. FDA GenAI comments.
10.17.25
5 min. Read
Revisiting E&O scoops, pricing intel, revenue finds
10.10.25
7 min. Read
Big Health’s 2024 revenue shrinks. 2025: Runway worries.
9.26.25
5 min. Read
Kavira Health pricing. What did Swing Therapeutics buy? PFS Comments.
9.18.25
7 min. Read
Cerebral’s $25M M&A. Amazon-Fay. Oshi growth numbers.
9.12.25
4 min. Read
Letters to CMS: DMHT codes, MDPP pricing, more. Plus: Unannounced funding.
9.05.25
6 min. Read
Pricing updates: Teladoc, Maven, Garner, Kaia and more
8.29.25
4 min. Read
  • First
  • Previous
  • 1 of 41
  • Next
  • Last